Kiniksa Pharmaceuticals International, plc — All Filings
702 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
15-15D
15-15D/A
3
4
424B4
424B5
5
8-A12B
8-K
8-K12B
ARS
CERT
CORRESP
CT ORDER
D
D/A
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
POS AM
PRE 14A
S-1
S-1/A
S-1MEF
S-3
S-8
S-8 POS
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G/A | — | 0000102909-26-001633 | Mar 27, 2026 | — |
| 4 | — | 0001835458-26-000006 | Mar 11, 2026 | Mar 9, 2026 |
| 144 | — | 0001921094-26-000294 | Mar 9, 2026 | — |
| SCHEDULE 13G | — | 0000315066-26-000640 | Mar 6, 2026 | — |
| 4 | — | 0001741533-26-000002 | Mar 4, 2026 | Mar 2, 2026 |
| 144 | — | 0001921094-26-000239 | Mar 2, 2026 | — |
| 10-K | 10-K | 0001104659-26-019168 | Feb 24, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001730430-26-000014 | Feb 24, 2026 | — |
| S-8 | FORM S-8 | 0001104659-26-019184 | Feb 24, 2026 | — |
| SCHEDULE 13G/A | — | 0001104659-26-015194 | Feb 13, 2026 | — |
| 4 | — | 0001384243-26-000004 | Feb 12, 2026 | Feb 10, 2026 |
| 4 | — | 0001835458-26-000004 | Feb 11, 2026 | Feb 9, 2026 |
| 4 | — | 0001454983-26-000002 | Feb 4, 2026 | Feb 1, 2026 |
| 4 | — | 0001384243-26-000002 | Feb 4, 2026 | Feb 2, 2026 |
| 8-K | 8-K | 0001730430-26-000010 | Jan 14, 2026 | Jan 10, 2026 |
| 8-K | 8-K | 0001730430-26-000005 | Jan 12, 2026 | — |
| 4 | — | 0001835458-26-000002 | Jan 9, 2026 | Jan 8, 2026 |
| 4 | — | 0001384243-25-000004 | Dec 17, 2025 | Dec 15, 2025 |
| 4 | — | 0001867899-25-000013 | Dec 17, 2025 | Dec 15, 2025 |
| 144 | — | 0001921094-25-001555 | Dec 15, 2025 | — |
| 4 | — | 0001835458-25-000007 | Dec 10, 2025 | Dec 8, 2025 |
| 144 | — | 0001921094-25-001502 | Dec 8, 2025 | — |
| 4 | — | 0001867899-25-000011 | Dec 1, 2025 | Nov 26, 2025 |
| 144 | — | 0001921094-25-001432 | Nov 26, 2025 | — |
| 4 | — | 0001867899-25-000009 | Nov 19, 2025 | Nov 17, 2025 |
| 144 | — | 0001921094-25-001388 | Nov 17, 2025 | — |
| 4 | — | 0001532218-25-000007 | Nov 14, 2025 | Nov 12, 2025 |
| 4 | — | 0001835458-25-000005 | Nov 14, 2025 | Nov 12, 2025 |
| 4 | — | 0001741533-25-000003 | Nov 4, 2025 | Oct 31, 2025 |
| 144 | — | 0001921094-25-001307 | Oct 31, 2025 | — |
| SCHEDULE 13G/A | — | 0000102909-25-000265 | Oct 31, 2025 | — |
| 4 | — | 0001835458-25-000003 | Oct 30, 2025 | Oct 28, 2025 |
| 10-Q | 10-Q | 0001104659-25-103180 | Oct 28, 2025 | Sep 30, 2025 |
| 144 | — | 0001921094-25-001298 | Oct 28, 2025 | — |
| 8-K | FORM 8-K | 0001104659-25-102834 | Oct 28, 2025 | — |
| 144 | — | 0001921094-25-001299 | Oct 28, 2025 | — |
| 4 | — | 0001532218-25-000005 | Oct 22, 2025 | Oct 20, 2025 |
| 4 | — | 0001464583-25-000005 | Oct 22, 2025 | Oct 20, 2025 |
| 144 | — | 0001921094-25-001279 | Oct 20, 2025 | — |
| 144 | — | 0001921094-25-001280 | Oct 20, 2025 | — |
| 4 | — | 0001867899-25-000007 | Oct 16, 2025 | Oct 14, 2025 |
| 144 | — | 0001921094-25-001257 | Oct 14, 2025 | — |
| 4 | — | 0001464583-25-000003 | Oct 8, 2025 | Oct 4, 2025 |
| 4 | — | 0001867899-25-000005 | Oct 1, 2025 | Sep 29, 2025 |
| 144 | — | 0001921094-25-001213 | Sep 29, 2025 | — |
| 4 | — | 0001867899-25-000003 | Sep 17, 2025 | Sep 15, 2025 |
| 144 | — | 0001921094-25-001156 | Sep 15, 2025 | — |
| 4 | — | 0001415889-25-023874 | Sep 8, 2025 | Sep 4, 2025 |
| 4 | — | 0001415889-25-023878 | Sep 8, 2025 | Sep 4, 2025 |
| 144 | — | 0001921094-25-001103 | Sep 5, 2025 | — |